基底细胞癌治疗市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

基底细胞癌治疗市场按治疗类型(手术、药物、其他)、最终用户和地理位置细分

市场快照

basal-cell-carcinoma-treatment-market_Market Summary
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 9.3 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

在预测期内,基底细胞癌治疗市场预计将以 9.3% 的复合年增长率增长。市场增长的主要因素是皮肤恶性肿瘤患病率的增加,各种环境因素的增加,这导致更多的紫外线照射和更容易患皮肤病的老年人口增加。

根据皮肤癌基金会的数据,大约 90% 的非黑色素瘤皮肤癌与暴露于紫外线辐射有关,而基底细胞癌是最常见的皮肤癌形式。据估计,美国每年诊断出 430 万例 BCC 病例。然而,基底细胞癌的高易感性仍未得到充分诊断和高昂的治疗成本是市场增长的制约因素。

报告范围

根据报告的范围,基底细胞癌是一种从基底细胞开始的皮肤癌,当旧细胞死亡时会产生新细胞。基底细胞癌治疗市场由治疗类型、最终用户和地理组成。

By Treatment Type
Surgery
Medication
Others
By End User
Hospitals
Specialty Clinics
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

基底细胞癌手术有望成为增长最快的部分

治疗基底细胞癌最常用的方法是手术切除。在这个过程中,外科医生切除了癌性病变和健康皮肤的周围边缘。在显微镜下检查剩余部分以确保没有癌细胞。对于不太可能复发的基底细胞癌,例如在胸部、背部、手部和足部形成的基底细胞癌,可能建议进行切除术。

在所有基底细胞癌的治疗方法中,手术切除因其最低的复发率、最高的治愈率和最佳的美容效果而被确立为更有效,导致它们的高需求。预计手术切除在未来几年仍将占主导地位,这证实了手术部分的主导地位。

根据美国皮肤病学会的数据,预计 2019 年美国将诊断出 95,830 例非侵袭性黑色素瘤病例,这进一步推动了市场的增长。

Skin Cancer Rates

北美在市场上占主导地位,预计在预测期内也会如此

在整个预测期内,预计北美将主导整个基底细胞癌治疗市场。这是由于该地区老年人口发病率上升、先进治疗意识提高、报销方案有利、基底细胞癌高发等因素。

在北美地区,由于老年人口数量的增加以及该国基底细胞癌数量的增加等因素,美国拥有最大的市场份额,预计将刺激该地区的需求。据美国皮肤病学会估计,美国每天约有 9,500 人被诊断出患有皮肤恶性肿瘤。因此,预计皮肤恶性肿瘤病例的增加推动了市场的增长。

Picture14.png

竞争格局

基底细胞癌治疗市场竞争适度,由几个主要参与者组成。目前主导市场的一些公司是默克公司、博士生健康公司、F. Hoffmann-La Roche Ltd.、Mylan NV、Sun Pharmaceuticals Ltd.、Allergan Inc.、Perrigo Company plc、Strides Arcolab Ltd. .

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Skin Cancers

      2. 4.2.2 Increase in Geriatric Population

      3. 4.2.3 Environmental Factors Leading to Greater Exposure of UV Radiation

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Treatment

      2. 4.3.2 High Susceptibility of Basal Cell Carcinoma to remain Under-diagnosed

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Treatment Type

      1. 5.1.1 Surgery

      2. 5.1.2 Medication

      3. 5.1.3 Others

    2. 5.2 By End User

      1. 5.2.1 Hospitals

      2. 5.2.2 Specialty Clinics

      3. 5.2.3 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Merck & Co. Inc

      2. 6.1.2 Bausch Health Companies Inc.

      3. 6.1.3 F. Hoffmann-La Roche AG

      4. 6.1.4 Sun Pharmaceuticals Ltd

      5. 6.1.5 Mylan N.V.

      6. 6.1.6 Abbvie (Allergan)

      7. 6.1.7 Perrigo Company plc

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Basal Cell Carcinoma Treatment Market market is studied from 2018 - 2026.

The Basal Cell Carcinoma Treatment Market is growing at a CAGR of 9.3% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Bausch Health Companies Inc., F. Hoffmann-La Roche AG, Mylan N.V., Sun Pharmaceuticals Ltd., Merck & Co. Inc. are the major companies operating in Basal Cell Carcinoma Treatment Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!